Illustration: Aïda Amer/Axios
China's growing role in global drug development and dealmaking took center stage at the Jefferies Global Healthcare Conference in London this week.
Why it matters: The country's progress is reshaping where American pharmaceutical companies look to bolster their pipelines and strike deals.